{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:31:23Z","timestamp":1789698683200,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ejpb.2021.08.016","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T11:21:35Z","timestamp":1630322495000},"page":"122-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Evaluation of two novel co-processed excipients for direct compression of orodispersible tablets and mini-tablets"],"prefix":"10.1016","volume":"168","author":[{"given":"Marcel","family":"Kokott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ard","family":"Lura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Breitkreutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Wiedey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2021.08.016_b0005","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.powtec.2019.07.048","article-title":"Comprehensive study of co-processed excipients F- Melts\u00ae: Flow, viscoelastic and compacts properties","volume":"355","author":"Sva\u010dinov\u00e1","year":"2019","journal-title":"Powder Technol."},{"issue":"7","key":"10.1016\/j.ejpb.2021.08.016_b0010","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1080\/10837450.2019.1615090","article-title":"Orally disintegrating tablets and orally disintegrating mini tablets\u2013novel dosage forms for pediatric use","volume":"24","author":"Comoglu","year":"2019","journal-title":"Pharm. Dev. Technol."},{"issue":"1","key":"10.1016\/j.ejpb.2021.08.016_b0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1517\/17425247.4.1.37","article-title":"Paediatric and geriatric drug delivery","volume":"4","author":"Breitkreutz","year":"2007","journal-title":"Expert Opin Drug Deliv"},{"issue":"3","key":"10.1016\/j.ejpb.2021.08.016_b0020","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ejpb.2011.02.005","article-title":"Orally disintegrating mini-tablets (ODMTs)\u2013a novel solid oral dosage form for paediatric use","volume":"78","author":"Stoltenberg","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.ejpb.2021.08.016_b0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejps.2015.02.015","article-title":"Orodispersible drug formulations for children and elderly","volume":"75","author":"Slavkova","year":"2015","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"10.1016\/j.ejpb.2021.08.016_b0030","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1208\/s12249-018-1104-2","article-title":"Co-Processed Excipients for Dispersible Tablets-Part 2: Patient Acceptability","volume":"19","author":"Dziemidowicz","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2021.08.016_b0035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1208\/s12249-009-9354-7","article-title":"Valsartan orodispersible tablets: formulation, in vitro\/in vivo characterization","volume":"11","author":"Ibrahim","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2021.08.016_b0040","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00702-003-0036-4","article-title":"A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition","volume":"110","author":"Clarke","year":"2003","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.ejpb.2021.08.016_b0045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0378-5173(98)00206-3","article-title":"Minitabletting: improving the compactibility of paracetamol powder mixtures","volume":"173","author":"Lennartz","year":"1998","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ejpb.2021.08.016_b0050","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.jpeds.2013.07.014","article-title":"Favorable acceptance of mini-tablets compared with syrup: a randomized controlled trial in infants and preschool children","volume":"163","author":"Klingmann","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.ejpb.2021.08.016_b0055","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jpeds.2015.07.010","article-title":"Acceptability of Uncoated Mini-Tablets in Neonates\u2013A Randomized Controlled Trial","volume":"167","author":"Klingmann","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.ejpb.2021.08.016_b0060","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.powtec.2017.12.021","article-title":"Functionality and performance evaluation of directly compressible co-processed excipients based on dynamic compaction analysis and percolation theory","volume":"326","author":"Dra\u0161kovi\u0107","year":"2018","journal-title":"Powder Technol."},{"issue":"5","key":"10.1016\/j.ejpb.2021.08.016_b0065","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1517\/17425247.2013.769955","article-title":"Compressed orally disintegrating tablets: excipients evolution and formulation strategies","volume":"10","author":"Al-khattawi","year":"2013","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.ejpb.2021.08.016_b0070","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijpharm.2018.05.061","article-title":"Characterization of mannitol granules and powder: A comparative study using two flowability testers","volume":"547","author":"Takeuchi","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ejpb.2021.08.016_b0075","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijpharm.2011.06.017","article-title":"Comparative evaluation of silicified microcrystalline cellulose II as a direct compression vehicle","volume":"416","author":"Rojas","year":"2011","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.ejpb.2021.08.016_b0080","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3109\/10837450.2012.685658","article-title":"Characterization, optimisation and process robustness of a co-processed mannitol for the development of orally disintegrating tablets","volume":"18","author":"Soh","year":"2013","journal-title":"Pharm Dev Technol"},{"issue":"6","key":"10.1016\/j.ejpb.2021.08.016_b0085","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1208\/s12249-018-1090-4","article-title":"Co-Processed Excipients for Dispersible Tablets-Part 1: Manufacturability","volume":"19","author":"Bowles","year":"2018","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.ejpb.2021.08.016_b0090","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.xphs.2016.09.026","article-title":"How Deformation Behavior Controls Product Performance After Twin Screw Granulation With High Drug Loads and Crospovidone as Disintegrant","volume":"106","author":"Meier","year":"2017","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.ejpb.2021.08.016_b0095","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/cpdd.728","article-title":"Relative Bioavailability of Enalapril Administered as Orodispersible Minitablets in Healthy Adults","volume":"9","author":"Van Hecken","year":"2020","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.ejpb.2021.08.016_b0100","unstructured":"A.W. Jenike, Storage and flow of solids, bulletin no. 123, Bulletin of the University of Utah, 53 (1964) 198."},{"key":"10.1016\/j.ejpb.2021.08.016_b0105","article-title":"Tableting of mini-tablets in comparison with conventionally sized tablets: A comparison of tableting properties and tablet dimensions","volume":"2","author":"Lura","year":"2020","journal-title":"International Journal of Pharmaceutics: X"},{"key":"10.1016\/j.ejpb.2021.08.016_b0110","first-page":"668","article-title":"Determination of tablet strength by the diametral compression tet","author":"Fell","year":"1970","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.08.016_b0115","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1007\/BF00547442","article-title":"Tensile fracture of doubly-convex cylindrical discs under diametral loading","volume":"23","author":"Pitt","year":"1988","journal-title":"J. Mater. Sci."},{"key":"10.1016\/j.ejpb.2021.08.016_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118804","article-title":"New orodispersible mini-tablets for paediatric use - A comparison of isomalt with a mannitol based co-processed excipient","volume":"572","author":"Lura","year":"2019","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ejpb.2021.08.016_b0125","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2017.11.021","article-title":"Orodispersible films: Product transfer from lab-scale to continuous manufacturing","volume":"535","author":"Thabet","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ejpb.2021.08.016_b0130","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.xphs.2017.12.002","article-title":"Understanding the Factors That Control the Quality of Mini-Tablet Compression: Flow Particle Size, and Tooling Dimension","volume":"107","author":"Zhao","year":"2018","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.ejpb.2021.08.016_b0135","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.powtec.2011.12.060","article-title":"Determination of the tensile strength of elongated tablets","volume":"238","author":"Pitt","year":"2013","journal-title":"Powder Technol."},{"key":"10.1016\/j.ejpb.2021.08.016_b0140","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.powtec.2013.10.007","article-title":"Compression prediction accuracy from small scale compaction studies to production presses","volume":"270","author":"Pitt","year":"2015","journal-title":"Powder Technol."},{"key":"10.1016\/j.ejpb.2021.08.016_b0145","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1002\/jps.24544","article-title":"The Disintegration Process in Microcrystalline Cellulose Based Tablets, Part 1: Influence of Temperature, Porosity and Superdisintegrants","volume":"104","author":"Yassin","year":"2015","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2021.08.016_b0150","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1208\/s12249-009-9227-0","article-title":"Disintegration of highly soluble immediate release tablets: a surrogate for dissolution","volume":"10","author":"Gupta","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2021.08.016_b0155","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3109\/10837450.2012.710238","article-title":"Evaluation of co-processed excipients used for direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus","volume":"18","author":"Brniak","year":"2013","journal-title":"Pharm Dev Technol"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121002289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121002289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:44:34Z","timestamp":1760546674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641121002289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":31,"alternative-id":["S0939641121002289"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.08.016","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of two novel co-processed excipients for direct compression of orodispersible tablets and mini-tablets","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}